title: Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression.
abstract: Latent infection of vascular cells with herpes-viruses may play a pathogenic role in the development of human atherosclerosis. In a previous study, we found that cultured human umbilical vein endothelial cells (HUVECs) infected with herpes simplex virus 1 (HSV-1) became procoagulant, exemplified both by their enhanced assembly of the prothrombinase complex and by their inability to reduce adhesion of platelets. We now report two further procoagulant consequences of endothelial HSV infection: loss of surface thrombomodulin (TM) activity and induction of synthesis of tissue factor. Within 4 hr of infection of HUVECs, TM activity measured by thrombin-dependent protein C activation declined 21 +/- 3% (P less than 0.05) and by 18 hr, 48 +/- 5% (P less than 0.001). Similar significant TM decrements accompanied infection of bovine aortic endothelial cells. Identical TM loss was induced with HSV-2 infection but not with adenovirus infection. Decreased surface expression of TM antigen (measured by the specific binding of a polyclonal antibody to bovine TM) closely paralleled the loss of TM activity. As examined by Northern blotting, these losses apparently reflected rapid onset (within 4 hr of HSV infection) loss of mRNA for TM. In contrast, HSV infection induced a viral-dose-dependent increase in synthesis of tissue factor protein, adding to the procoagulant state. The results indicate that loss of endothelial protein-synthetic capacity is not a universal effect of HSV infection. We suggest that the procoagulant state induced by reduction in TM activity and amplified tissue factor activity accompanying HSV infection of endothelium could contribute to deposition of thrombi on atherosclerotic plaques and to the "coagulant-necrosis" state that characterizes HSV-infected mucocutaneous lesions.
authors.affiliation: Department of Medicine, University of Minnesota, Minneapolis 55455.
authors.forename: N S
authors.initials: NS
authors.lastname: Key
authors.forename: G M
authors.initials: GM
authors.lastname: Vercellotti
authors.forename: J C
authors.initials: JC
authors.lastname: Winkelmann
authors.forename: C F
authors.initials: CF
authors.lastname: Moldow
authors.forename: J L
authors.initials: JL
authors.lastname: Goodman
authors.forename: N L
authors.initials: NL
authors.lastname: Esmon
authors.forename: C T
authors.initials: CT
authors.lastname: Esmon
authors.forename: H S
authors.initials: HS
authors.lastname: Jacob
mesh_terms: D002472:Cell Transformation, Viral; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000378:metabolism*; D006801:Humans; D007375:Interleukin-1 / Q000096:biosynthesis / Q000378:metabolism; D007700:Kinetics; D012333:RNA, Messenger / Q000032:analysis / Q000235:genetics; D011956:Receptors, Cell Surface / Q000032:analysis / Q000096:biosynthesis / Q000235:genetics*; D018179:Receptors, Thrombin; D018139:Simplexvirus / Q000235:genetics*; D013925:Thromboplastin / Q000378:metabolism*; D014471:Umbilical Veins
chemical_list: D007375:Interleukin-1; D012333:RNA, Messenger; D011956:Receptors, Cell Surface; D018179:Receptors, Thrombin; D013925:Thromboplastin